Journal of Telemedicine and Telecare,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 17, 2025
Introduction
The
COVID-19
pandemic
exacerbated
existing
challenges
in
treating
substance
use
disorders.
This
study
explores
the
impact
of
telehealth
on
addiction
consult
services
(ACS)
medication
initiation
hospitalized
patients
with
alcohol
and
opioid
disorders
(AUD
OUD).
Methods
We
retrospectively
analyzed
data
from
adult
who
received
their
first
ACS
consultation
in-person
(pre-pandemic)
(during
pandemic).
compared
rates
for
AUD
OUD
before
after
consultation.
Results
completed
398
consults
473
consults.
In-person
increased
3.41%
without
an
consult,
to
45.45%
consult.
For
pharmacotherapy
initiation,
6.94%
41.67%
OUD.
Telehealth
5.16%
66.20%
7.53%
67.74%
Buprenorphine
naltrexone
were
most
commonly
initiated
medications
AUD,
respectively.
Discussion
adoption
by
hospital
during
effectively
OUD,
consistent
pre-pandemic,
demonstrating
its
potential
expand
access
services.
approach
could
address
current
shortage
providers
serve
underserved
populations.
Journal of Addiction Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 17, 2025
Objectives:
Individuals
with
stimulant
use
disorders
(StSUDs)
present
an
elevated
risk
of
cardiovascular
complications
compared
the
general
population.
However,
it
remains
unclear
whether,
within
subpopulation
individuals
substance
(SUDs),
those
specifically
affected
by
StSUDs
face
even
higher
complications.
Methods:
We
conducted
a
retrospective
cohort
study
using
EVERSANA
databank,
spanning
from
January
2015
to
December
2023.
The
data
set
comprises
deidentified
electronic
health
record
aggregated
and
standardized
across
United
States.
Participants
included
patients
diagnosed
SUDs,
encompassing
alcohol,
cannabis,
opioids,
stimulants,
tobacco,
hallucinogens,
sedative-hypnotics,
or
inhalants.
employed
International
Classification
Disease
10th
(ICD-10)
version
codes
define
presence
StSUD
SUD.
Major
adverse
cardiac
events
(MACE)
were
assessed,
Cox
proportional
hazard
ratios
adjusted
high-dimensional
propensity
score
(hdPS)
matching
account
for
potential
confounders.
Results:
Among
137,106
SUD,
7706
(5.6%)
had
StSUD.
was
50.2%
female,
53.0%
non-White,
mean
age
49.1
years
(SD±15).
After
adjustment,
users
exhibited
significantly
MACE
rates
(HR=1.37,
95%
CI:
1.22–1.53,
P
<0.001),
including
death
(HR=1.23,
1.02–1.47,
=0.026).
Conclusion:
increased
nonstimulant
SUDs.
Journal of Psychoactive Drugs,
Год журнала:
2025,
Номер
unknown, С. 1 - 9
Опубликована: Март 3, 2025
Little
is
known
about
ecstasy/MDMA
use
among
Asian
American
and
Pacific
Islander
populations.
Research
important
because
AAPIs
face
unique
cultural
factors
that
may
influence
use.
We
estimated
the
prevalence
correlates
of
lifetime
based
on
a
representative
sample
US
AAPI
adults
aged
≥18
from
2015–2020
National
Survey
Drug
Use
Health.
An
5.1%
used
ecstasy
in
their
lifetime.
Compared
to
males,
females
had
higher
odds
(aOR
=
1.45,
95%
CI:
1.08–1.98).
those
18–25,
26–34
were
at
increased
for
1.99,
1.30–3.06),
while
≥50
lower
Lifetime
other
substances
including
cannabis
28.4,
17.1–47.2),
ketamine
10.9,
1.63–73.4),
LSD
3.82,
1.98–7.37),
cocaine
3.77,
2.54–5.59),
psilocybin
3.29,
1.75–6.16),
prescription
opioids
2.43,
1.44–4.09),
stimulants
1.96,
1.29–2.99)
associated
with
over
1
20
have
ever
ecstasy/MDMA.
Variations
by
age,
sex,
family
income,
substance
type,
mental
health
service
utilization
emphasize
need
targeted
public
strategies.
Journal of Telemedicine and Telecare,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 17, 2025
Introduction
The
COVID-19
pandemic
exacerbated
existing
challenges
in
treating
substance
use
disorders.
This
study
explores
the
impact
of
telehealth
on
addiction
consult
services
(ACS)
medication
initiation
hospitalized
patients
with
alcohol
and
opioid
disorders
(AUD
OUD).
Methods
We
retrospectively
analyzed
data
from
adult
who
received
their
first
ACS
consultation
in-person
(pre-pandemic)
(during
pandemic).
compared
rates
for
AUD
OUD
before
after
consultation.
Results
completed
398
consults
473
consults.
In-person
increased
3.41%
without
an
consult,
to
45.45%
consult.
For
pharmacotherapy
initiation,
6.94%
41.67%
OUD.
Telehealth
5.16%
66.20%
7.53%
67.74%
Buprenorphine
naltrexone
were
most
commonly
initiated
medications
AUD,
respectively.
Discussion
adoption
by
hospital
during
effectively
OUD,
consistent
pre-pandemic,
demonstrating
its
potential
expand
access
services.
approach
could
address
current
shortage
providers
serve
underserved
populations.
